FDA drug approvals

FDA new drug approvals drop in 2013 but include first 3 ‘breakthrough’ therapies

Following a 15-year high in 2012, new FDA drug approvals were down last year. Among the 27 new drugs approved in 2013 were eight new cancer therapies, three diagnostic imaging agents and three medicines that received expedited review under the FDA’s new “breakthrough therapy” designation program. That’s about on par with the average over the […]